13 Ovarian Cancer Clinical Trials in Oklahoma City, OK (2026)

Q: How do I join a clinical trial in Oklahoma City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you.

Recruiting Ovarian Cancer Studies in Oklahoma City

NCT00539162Recruiting

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

The goal of this clinical research study is to find out if combining a standard blood test (CA-125) that checks for ovarian cancer with other blood tests that check for related tumor markers may be he...

Oklahoma City, OKNA8,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT03564340Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

The main purpose of this study is to: * Learn about the safety of ubamatamab and to find out what dose of ubamatamab can be given alone or with cemiplimab to patients with ovarian cancer or cancer of...

Oklahoma City, OKPHASE1890 participantsRegeneron Pharmaceuticals

View Study Details

NCT06843447Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Researchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came back after treatment. High-grade means the cancer cells grow and spread quickl...

Oklahoma City, OKPHASE1460 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05107674Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies....

Oklahoma City, OKPHASE1345 participantsNurix Therapeutics, Inc.

View Study Details

NCT06751329Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

The goal of study： The study has two parts: Part 1 Dose Escalation and Part 2 Dose Expansion. In Part 1, a few participants will receive the lowest dose of study drug. The study team will make sure ...

Oklahoma City, OKPHASE1280 participantsXadcera Biopharmaceutical (Suzhou) Co., Ltd.

View Study Details

NCT06234423Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors....

Oklahoma City, OKPHASE1263 participantsOnCusp Therapeutics, Inc.

View Study Details

NCT06303505Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

The purpose of this multicentric, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy of TUB-040 and to find the best dose of TUB-040 in ...

Oklahoma City, OKPHASE1250 participantsTubulis GmbH

View Study Details

NCT04606914Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC. Patients with biopsy confirmed, newly diagnosed,...

Oklahoma City, OKPHASE270 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06888921Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

The goal of this clinical trial is to learn if the experimental antibody COM701 delays the progression of ovarian cancer in participants with Relapsed Platinum Sensitive Ovarian Cancer. It will also l...

Oklahoma City, OKPHASE160 participantsCompugen Ltd

View Study Details

NCT03877796Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

The patient's local archival tumor tissue (FFPE) from original tumor, or from the metastatic tissue, will be collected to potentially identify if they - at a later stage of their disease - will be lik...

Oklahoma City, OK60 participantsAllarity Therapeutics

View Study Details

NCT05512208Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

The purpose of this research is to test the effectiveness and safety of the study drugs (VS-6766 and defactinib), and see what effects (good and bad) these drugs have on the patients with endometrioid...

Oklahoma City, OKPHASE255 participantsUniversity of Oklahoma

View Study Details

NCT03878849Recruiting

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

The purpose of this study is to evaluate the optimal dose of 2X-121 as single agent therapy at 600 mg daily (split BID 200 mg morning + 400 mg evening) compared to 800 mg daily (split BID 400 mg morni...

Oklahoma City, OKPHASE240 participantsAllarity Therapeutics

View Study Details

NCT05739981Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

This is a 1:1 randomized, open label, multi-center phase I/II trial to evaluate the safety, dosing, efficacy, and biological activity of adding IMNN-001 to chemotherapy + BEV compared to chemotherapy ...

Oklahoma City, OKPHASE130 participantsImunon

View Study Details

About Ovarian Cancer Clinical Trials in Oklahoma City

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 13 ovarian cancer clinical trials recruiting participants in Oklahoma City, OK. These studies are seeking a combined 10,803 participants. Research is being sponsored by M.D. Anderson Cancer Center, Regeneron Pharmaceuticals, Merck Sharp & Dohme LLC and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Oklahoma City — FAQ

Are there ovarian cancer clinical trials in Oklahoma City?

Yes, there are 13 ovarian cancer clinical trials currently recruiting in Oklahoma City, OK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oklahoma City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.

Are clinical trials in Oklahoma City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 13 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 18, 2026 from ClinicalTrials.gov